Cover Image
Market Research Report

APAC Contract Research Organisation (CRO) Market

Published by Frost & Sullivan Product code 335337
Published Content info 149 Pages
Delivery time: 1-2 business days
Price
Back to Top
APAC Contract Research Organisation (CRO) Market
Published: July 10, 2015 Content info: 149 Pages
Description

An Analysis of Trends Transforming the CRO Industry

The research service presents an overview and analysis of the Asia-Pacific (APAC) contract research organisation (CRO) market and provides revenue forecasts by phase and therapeutic type. It discusses the major issues and challenges, unmet needs, and emerging trends in the market and covers the complete life cycle of the CRO industry, from pre-clinical trials to post marketing surveillance. Moreover, it provides detailed information on support services such as central laboratory services, bio-analytics, and data management. The research service also analyses market drivers and restraints, and provides market engineering measurements and research and development trends.

Key Questions This Study Will Answer

  • How will contract research outsourcing help in drug development by saving time and cost for manufacturers?
  • What is the impact of market growth in different countries in APAC?
  • Which are the major participants in the APAC CRO market and what are their market shares?
  • Which are the factors contributing toward expansion of CROs across the key therapeutic areas?
  • Are the products/services offered in APAC currently meeting customer needs or is additional development needed?
  • Which are the key market segments to look out for and what are the key trends in the APAC market?
Table of Contents
Product Code: P86A-01-00-00-00

Table of Contents

1. EXECUTIVE SUMMARY

  • 1. Key Findings
  • 2. Key Findings (continued)
  • 3. Key Findings (continued)
  • 4. Key Findings (continued)
  • 5. Key Findings (continued)
  • 6. Total CRO Market Size-By Stages of Clinical Development
  • 7. Market Size Estimation Methodology
  • 8. Scope and Segmentation
  • 9. Key Questions This Study Will Answer
  • 10. Total CRO Market Engineering Measurements
  • 11. Total CRO Market Engineering Measurements (continued)
  • 12. CEO's Perspective
  • 13. Key Companies to Watch
  • 14. Key Companies to Watch (continued)
  • 15. 3 Big Predictions

2. MARKET OVERVIEW

  • 1. R&D Spending-Pharmaceutical Drug Development
  • 2. Market Perspective
  • 3. R&D Market Landscape
  • 4. CRO Product Development and Commercialization
  • 5. Total CRO Market Segmentation-By Stages of Clinical Development
  • 6. Total CRO Market Segmentation-By Therapeutic Services
  • 7. Key Market Trends
  • 8. eClinical Solutions-An Overview
  • 9. eClinical Solutions-Applications and Technologies
  • 10. Rise of Virtual Business Models

3. COMPETITIVE PLAYBOOK

  • 1. New Market Opportunities
  • 2. New Market Opportunities (continued)
  • 3. New Market Opportunities (continued)
  • 4. New Market Opportunities (continued)
  • 5. Merger, Acquisition and Partnership Assessment
  • 6. Merger, Acquisition and Partnership Assessment (continued)
  • 7. Competitive Matrix

4. DRIVERS, RESTRAINTS, AND TRENDS

  • 1. Market Drivers
  • 2. Market Restraints

5. FORECASTS AND TRENDS-TOTAL CRO MARKET

  • 1. Forecast Assumptions
  • 2. Total CRO Market Engineering Measurements
  • 3. Total CRO Market Engineering Measurements (continued)
  • 4. Total CRO Market-Revenue Forecast
  • 5. Total CRO Market-Revenue Forecast Discussion
  • 6. Key Market Trends
  • 7. Key Market Trends Explained
  • 8. Key Market Trends Explained (continued)
  • 9. Key Market Trends Explained (continued)

6. COMPETITIVE ENVIRONMENT

  • 1. Competitive Analysis-Market Share
  • 2. Market Share Analysis
  • 3. Competitive Environment
  • 4. Competitive Analysis-Selected Key Market Participants
  • 5. Competitive Analysis-Selected Key Market Participants (continued)
  • 6. Competitive Analysis-Selected Key Market Participants (continued)
  • 7. Competitive Analysis-Selected Key Market Participants (continued)
  • 8. Competitive Analysis-Selected Key Market Participants (continued)
  • 9. Competitive Analysis-Selected Key Market Participants (continued)
  • 10. Competitive Analysis-Selected Key Market Participants (continued)
  • 11. Competitive Analysis-Selected Key Market Participants (continued)

7. PRE-CLINICAL TRIALS SEGMENT BREAKDOWN

  • 1. Pre-Clinical Trials Segment Overview
  • 2. Pre-Clinical Trials Segment-Market Engineering Measurements
  • 3. Pre-Clinical Trials Segment-Revenue Forecast
  • 4. Pre-Clinical Trials Segment-Revenue Forecast Discussion
  • 5. Pre-Clinical Trials Segment Key Trends

8. PHASE I TRIALS SEGMENT BREAKDOWN

  • 1. Phase I Trials Segment Overview
  • 2. Phase I Trials Segment-Market Engineering Measurements
  • 3. Phase I Trials Segment-Revenue Forecast
  • 4. Phase I Trials Segment-Revenue Forecast Discussion
  • 5. Phase I Trials Segment Key Trends

9. PHASE II TRIALS SEGMENT BREAKDOWN

  • 1. Phase II Trials Segment Overview
  • 2. Phase II Trials Segment-Market Engineering Measurements
  • 3. Phase II Trials Segment-Revenue Forecast
  • 4. Phase II Trials Segment-Revenue Forecast Discussion
  • 5. Phase II Trials Segment Key Trends*

10. PHASE III TRIALS SEGMENT BREAKDOWN

  • 1. Phase III Trials Segment Overview
  • 2. Phase III Trials Segment-Market Engineering Measurements
  • 3. Phase III Trials Segment-Revenue Forecast
  • 4. Phase III Trials Segment-Revenue Forecast Discussion
  • 5. Phase III Trials Segment Key Trends*

11. PHASE IV TRIALS SEGMENT BREAKDOWN

  • 1. Phase IV Trials Segment Overview
  • 2. Phase IV Trials Segment-Market Engineering Measurements
  • 3. Phase IV Trials Segment-Revenue Forecast
  • 4. Phase IV Trials Segment-Revenue Forecast Discussion
  • 5. Phase IV Trials Segment Key Trends

12. DATA MANAGEMENT SEGMENT BREAKDOWN

  • 1. Data Management Segment Overview
  • 2. Data Management Segment-Market Engineering Measurements
  • 3. Data Management Segment-Revenue Forecast
  • 4. Data Management Segment-Revenue Forecast Discussion
  • 5. Data Management Segment Key Trends

13. BIOSTATISTICS SEGMENT BREAKDOWN

  • 1. Biostatistics Segment Overview
  • 2. Biostatistics Segment-Market Engineering Measurements
  • 3. Biostatistics Segment-Revenue Forecast
  • 4. Biostatistics Segment-Revenue Forecast Discussion
  • 5. Biostatistics Segment Key Trends

14. PHARMACOVIGILANCE SEGMENT BREAKDOWN

  • 1. Pharmacovigilance Segment Overview
  • 2. Pharmacovigilance Segment-Market Engineering Measurements
  • 3. Pharmacovigilance Segment-Revenue Forecast
  • 4. Pharmacovigilance Segment-Revenue Forecast Discussion
  • 5. Pharmacovigilance Segment Key Trends

15. HEALTH ECONOMICS AND OUTCOMES RESEARCH (HEOR) SEGMENT BREAKDOWN

  • 1. HEOR Segment Overview
  • 2. HEOR Segment-Market Engineering Measurements
  • 3. HEOR Segment-Revenue Forecast
  • 4. HEOR Segment-Revenue Forecast Discussion
  • 5. HEOR Segment Key Trends

16. BIO-ANALYTICS SEGMENT

  • 1. Bio-Analytics Segment Overview
  • 2. Bio-Analytics Segment-Market Engineering Measurements
  • 3. Bio-Analytics Segment-Revenue Forecast
  • 4. Bio-Analytics Segment-Revenue Forecast Discussion
  • 5. Bio-Analytics Segment Key Trends

17. CENTRAL LABORATORY SERVICES SEGMENT BREAKDOWN

  • 1. Central Laboratory Services Segment Overview
  • 2. Central Laboratory Services Segment-Market Engineering Measurements
  • 3. Central Laboratory Services Segment-Revenue Forecast
  • 4. Central Laboratory Services Segment-Revenue Forecast Discussion
  • 5. Central Laboratory Services Segment Key Trends

18. THE LAST WORD

  • 1. 3 Big Predictions
  • 2. The Last Word-Discussion
  • 3. Legal Disclaimer

19. APPENDIX

  • 1. Methodology
  • 2. Drivers Explained
  • 3. Drivers Explained (continued)
  • 4. Restraints Explained
  • 5. Restraints Explained (continued)
  • 6. List of Exhibits
  • 7. List of Exhibits (continued)
  • 8. List of Exhibits (continued)
Back to Top